Peripheral T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Peripheral T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Chidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell Lymphoma [Phase 1, Phase 2]
Clinical trial update on chidamide plus golidocitinib for relapsed/refractory peripheral T-cell lymphoma, spanning Phase 1 and Phase 2; curr…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating the CAMP regimen—chidamide in combination with azacitidine, liposomal mitoxantrone, and prednisone—fo…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Golidocitinib Plus CHOP in Newly Diagnosed PTCL [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating golidocitinib plus CHOP for newly diagnosed peripheral T-cell lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) [Phase 1, Phase 2]
GFH009 is being studied as a single-agent therapy in relapsed or refractory Peripheral T-cell Lymphoma, with Phase 1/2 trials currently recr…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) [Phase 1]
Phase 1 trial evaluating linperlisib in combination with an EZH2 inhibitor for relapsed/refractory peripheral T-cell lymphoma; the study is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: To Evaluate XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma [Phase 2]
A Phase 2 clinical trial to evaluate XNW5004 tablets in relapsed or refractory peripheral T-cell lymphoma has not yet begun recruiting.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating sequential CD5/CD7-specific CAR-T cells for CD5/CD7-positive T-cell malignancies including T-…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma [NA]
This clinical trial investigates pralatrexate in combination with chidamide as a bridging therapy to allogeneic stem cell transplantation fo…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating azacitidine plus the CAOLD regimen in relapsed or refractory Peripheral T-cell lymphoma; currently recru…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma [NA]
This clinical trial update describes a pilot study using a microdevice to screen candidate drugs in cutaneous lesions from patients with cut…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL). [Phase 2]
A Phase 2 clinical trial assessing the efficacy of chidamide for CD30-positive peripheral T-cell lymphoma. The trial is currently active but…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma [Phase 2, Phase 3]
Clinical trial update for a Phase II/III study of Linperlisib plus CHOP versus CHOP in newly diagnosed peripheral T-cell lymphoma, currently…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers [Phase 1, Phase 2]
Phase I/IIa clinical trial update for BR1733 in advanced cancers, including follicular lymphoma, peripheral T-cell lymphoma, and diffuse lar…
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL [NA]
A clinical trial is evaluating allogeneic peripheral blood stem cell transplantation as first-line therapy for high-risk peripheral T-cell l…
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL. [Phase 2]
A Phase 2 trial assessing reduced-intensity conditioning with thiotepa plus busulfan/fludarabine/cytarabine in allogeneic HSCT for relapsed …
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma [Phase 2]
The document notes a Phase 2 clinical trial evaluating CMOEP for untreated Peripheral T-cell lymphoma, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Linperlisib in combination with CHOP for previously untreated Peripheral T-cell lymphoma is currently …
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)
A real-world registry study (TRUST) investigating molecular subtypes of Peripheral T-cell lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma [Phase 1, Phase 2]
A clinical trial update announcing a Phase 1/2 study of SHR2554 in combination with chemotherapy for treatment-naïve peripheral T-cell lymph…
-
CLINICAL_TRIALS research · 2017-11-14Clinical Trial Update: Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating chidamide in combination with chemotherapy for peripheral T-cell lymphoma. The trial status is currently unknown.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: T-Cell Project: Epidemiologic Component
Update on the completion of the epidemiologic component of the National Cancer Institute's T-Cell Project studying Peripheral T-Cell Lymphom…
-
CLINICAL_TRIALS research · 2017-03-31Clinical Trial Update: The Value and Mechanisms for Monocytes Subpopulations in Predicting the Prognosis of Lymphomas
This clinical trial explores whether monocyte subpopulations can predict prognosis in lymphomas, including diffuse large B-cell lymphoma. It…
-
CLINICAL_TRIALS research · 2017-03-27Clinical Trial Update: Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients
The trial update examines circulating tumor DNA as a biomarker to predict relapse and overall survival in non-Hodgkin lymphoma patients, inc…
-
CLINICAL_TRIALS research · 2017-03-21Clinical Trial Update: A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas
This clinical trial update reports a retrospective analysis of clinical, phenotypic, and genetic factors in peripheral T-cell lymphomas. The…
-
CLINICAL_TRIALS research · 2017-02-13Clinical Trial Update: 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma [NA]
This entry reports an ongoing clinical trial evaluating an 18F-FDG PET/CT–based prognostic model to predict outcomes in patients with periph…